DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Kaufman B, Mackey JR et al.
Trastuzumab plusanastrozole versus anastrozole alone for the treatment ofpostmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from therandomized phase III TAnDEM Study.
J ClinOncol 2009;
27: 5529-5537
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.